These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 38472558)
1. Integrated analysis reveals an aspartate metabolism-related gene signature for predicting the overall survival in patients with hepatocellular carcinoma. Shi J; Wen K; Mui S; Li H; Liao H; He C; Yan Y; Zhou Z; Xiao Z Clin Transl Oncol; 2024 Sep; 26(9):2181-2197. PubMed ID: 38472558 [TBL] [Abstract][Full Text] [Related]
2. A Novel Amino Acid-Related Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma. Wang S; Huang H; Hu X; Xiao M; Yang K; Bu H; Jiang Y; Huang Z Cancer Rep (Hoboken); 2024 Jul; 7(7):e2131. PubMed ID: 39041652 [TBL] [Abstract][Full Text] [Related]
3. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma. Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma. Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474 [TBL] [Abstract][Full Text] [Related]
5. Immune- and metabolism-related gene signature analysis uncovers the prognostic and immune microenvironments of hepatocellular carcinoma. Gu Y; Ma E; Jiang S; Shan Z; Xia G; Ma R; Fu J; Wang Z J Cancer Res Clin Oncol; 2024 Jun; 150(6):311. PubMed ID: 38896142 [TBL] [Abstract][Full Text] [Related]
6. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment. Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776 [TBL] [Abstract][Full Text] [Related]
7. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma. Wang S; Bai H; Fei S; Miao B Biochem Genet; 2024 Jun; 62(3):2332-2351. PubMed ID: 37898914 [TBL] [Abstract][Full Text] [Related]
8. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma. Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790 [TBL] [Abstract][Full Text] [Related]
9. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
10. Identification of a four-gene metabolic signature predicting overall survival for hepatocellular carcinoma. Liu GM; Xie WX; Zhang CY; Xu JW J Cell Physiol; 2020 Feb; 235(2):1624-1636. PubMed ID: 31309563 [TBL] [Abstract][Full Text] [Related]
11. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma. Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373 [TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
13. Fatty acid metabolism affects hepatocellular carcinoma progression via the PPAR-γ signaling pathway and fatty acid β-oxidation. Feng W; Liang J; Xu B; Huang L; Xu Q; Chen D; Lai J; Chen J Int Immunopharmacol; 2024 Nov; 141():112917. PubMed ID: 39137630 [TBL] [Abstract][Full Text] [Related]
14. A prognostic signature established based on genes related to tumor microenvironment for patients with hepatocellular carcinoma. Cui Z; Li G; Shi Y; Zhao X; Wang J; Hu S; Chen C; Li G Aging (Albany NY); 2024 Apr; 16(7):6537-6549. PubMed ID: 38579170 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
16. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma. Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955 [TBL] [Abstract][Full Text] [Related]
17. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma. Dai K; Liu C; Guan G; Cai J; Wu L BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781 [TBL] [Abstract][Full Text] [Related]
18. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177 [TBL] [Abstract][Full Text] [Related]
19. A Novel RNA Methylation-Related Prognostic Signature and its Tumor Microenvironment Characterization in Hepatocellular Carcinoma. Liu L; Chen J; Ye F; Yan Y; Wang Y; Wu J Technol Cancer Res Treat; 2024; 23():15330338241276895. PubMed ID: 39155614 [TBL] [Abstract][Full Text] [Related]
20. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma. Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]